Ganzkörper-MRT bei Tumorprädispositionssyndromen

Ahlawat S, Blakeley JO, Langmead S et al (2020) Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skelet Radiol 49:199–219

Anupindi SA, Bedoya MA, Lindell RB et al (2015) Diagnostic performance of whole-body MRI as a tool for cancer screening in children with genetic cancer-predisposing conditions. AJR Am J Roentgenol 205:400–408

Ballinger ML, Best A, Mai PL et al (2017) Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis. JAMA Oncol 3:1634–1639

Davis JT, Kwatra N, Schooler GR (2016) Pediatric whole-body MRI: a review of current imaging techniques and clinical applications. J Magn Reson Imaging 44:783–793

Dong SZ, Zhu M, Bulas D (2019) Techniques for minimizing sedation in pediatric MRI. J Magn Reson Imaging 50:1047–1054

Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 2 and related disorders. Clin Cancer Res 23:e54–e61

Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res 23:e46–e53

Friedman DN, Hsu M, Moskowitz CS et al (2020) Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: an update. Pediatr Blood Cancer 67:e28389

Gatidis S, Guckel B, La Fougere C et al (2016) Simultaneous whole-body PET-MRI in pediatric oncology: more than just reducing radiation? Radiologe 56:622–630

Geiger J, Zeimpekis KG, Jung A et al (2021) Clinical application of ultrashort echo-time MRI for lung pathologies in children. Clin Radiol 76(9):708.e9–708.e17

Goo HW (2010) Whole-body MRI of neuroblastoma. Eur J Radiol 75(3):306–314. https://doi.org/10.1016/j.ejrad.2009.09.014

Grasparil AD 2nd, Gottumukkala RV, Greer MC et al (2020) Whole-body MRI surveillance of cancer predisposition syndromes: current best practice guidelines for use, performance, and interpretation. AJR Am J Roentgenol 215:1002–1011

Greer MC (2018) Imaging of cancer predisposition syndromes. Pediatr Radiol 48:1364–1375

Greer MC (2018) Whole-body magnetic resonance imaging: techniques and non-oncologic indications. Pediatr Radiol 48:1348–1363

Greer MC, Voss SD, States LJ (2017) Pediatric cancer predisposition imaging: focus on whole-body MRI. Clin Cancer Res 23:e6–e13

Guimaraes JB, da Cruz IAN, Ahlawat S et al (2021) The role of whole-body MRI in pediatric musculoskeletal oncology: current concepts and clinical applications. J Magn Reson Imaging. https://doi.org/10.1002/jmri.27787

Kamihara J, Bourdeaut F, Foulkes WD et al (2017) Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res 23:e98–e106

Kratz CP, Achatz MI, Brugieres L et al (2017) Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res 23:e38–e45

Kumamoto T, Yamazaki F, Nakano Y et al (2021) Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1. Int J Clin Oncol 26:2161–2178

Lemaire C, Moran GR, Swan H (2009) Impact of audio/visual systems on pediatric sedation in magnetic resonance imaging. J Magn Reson Imaging 30:649–655

Littooij AS, Kwee TC, De Keizer B et al (2015) Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: a prospective multicenter study. J Magn Reson Imaging 42:1646–1655

McGee K (2003) The role of a child life specialist in a pediatric radiology department. Pediatr Radiol 33:467–474

Müller-Horvat C, Plathow C, Ludescher B et al (2007) Generating statements at whole-body imaging with a workflow-optimized software tool—first experiences with multireader analysis. Rofo 179:721–727

Olsen OE (2008) Practical body MRI—a paediatric perspective. Eur J Radiol 68:299–308

Olthof SC, Reinert C, Nikolaou K et al (2021) Detection of lung lesions in breath-hold VIBE and free-breathing spiral VIBE MRI compared to CT. Insights Imaging 12:175

Rednam SP, Erez A, Druker H et al (2017) Von Hippel-Lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood. Clin Cancer Res 23:e68–e75

Reinert CP, Schuhmann MU, Bender B et al (2019) Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI. Eur J Nucl Med Mol Imaging 46:776–787

Saade-Lemus S, Degnan AJ, Acord MR et al (2019) Whole-body magnetic resonance imaging of pediatric cancer predisposition syndromes: special considerations, challenges and perspective. Pediatr Radiol 49:1506–1515

Schaefer J, Berthold L, Hahn G (2019) Ganzkörper-Magnetresonanztomografie im Kindes-und Jugendalter – S1-Leitlinie. Fortschr Röntgenstr 191:618–625

Schaefer JF, Kramer U (2011) Whole-body MRI in children and juveniles. Rofo 183:24–36

Schaefer JF, Schlemmer HP (2006) Total-body MR-imaging in oncology. Eur Radiol 16:2000–2015

Schäfer JF, Granata C, Von Kalle T et al (2020) Whole-body magnetic resonance imaging in pediatric oncology—recommendations by the Oncology Task Force of the ESPR. Pediatr Radiol 50:1162–1174

Törnqvist E, Månsson Å, Hallström I (2015) Children having magnetic resonance imaging: a preparatory storybook and audio/visual media are preferable to anesthesia or deep sedation. J Child Health Care 19:359–369

Villani A, Shore A, Wasserman JD et al (2016) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol 17:1295–1305

Zadig P, Von Brandis E, D’Angelo P et al (2022) Whole-body MRI in children aged 6–18 years. Reliability of identifying and grading high signal intensity changes within bone marrow. Pediatr Radiol 52:1272–1282